

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.09818866 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.09818866 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.07842621 |
| 4 | negative T cell selection (GO:0043383) | 5.85397527 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.73522588 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.58219521 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.51802144 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.51348208 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.29111091 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.22118410 |
| 11 | activated T cell proliferation (GO:0050798) | 5.01909558 |
| 12 | tolerance induction (GO:0002507) | 4.96775213 |
| 13 | DNA deamination (GO:0045006) | 4.92994404 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.86537965 |
| 15 | response to interleukin-15 (GO:0070672) | 4.79818198 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69528958 |
| 17 | cytidine deamination (GO:0009972) | 4.62963045 |
| 18 | cytidine metabolic process (GO:0046087) | 4.62963045 |
| 19 | cytidine catabolic process (GO:0006216) | 4.62963045 |
| 20 | positive T cell selection (GO:0043368) | 4.58784390 |
| 21 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.49459529 |
| 22 | leukocyte aggregation (GO:0070486) | 4.33464346 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.30427723 |
| 24 | positive thymic T cell selection (GO:0045059) | 4.29895367 |
| 25 | thymic T cell selection (GO:0045061) | 4.21447595 |
| 26 | T cell selection (GO:0045058) | 4.20752787 |
| 27 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.16602697 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.15433689 |
| 29 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.14790361 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 4.11900489 |
| 31 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.07829931 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.05532485 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.88365843 |
| 34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.86053046 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.85741805 |
| 36 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.76745052 |
| 37 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.76745052 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.76218324 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75436369 |
| 40 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.67821327 |
| 41 | T cell migration (GO:0072678) | 3.62960020 |
| 42 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.62949098 |
| 43 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.62071086 |
| 44 | positive regulation of tolerance induction (GO:0002645) | 3.61735304 |
| 45 | mast cell activation (GO:0045576) | 3.48351248 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46555439 |
| 47 | interferon-gamma production (GO:0032609) | 3.43475216 |
| 48 | positive regulation of defense response to virus by host (GO:0002230) | 3.41694112 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.41201719 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.39318377 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38085535 |
| 52 | positive regulation of granulocyte differentiation (GO:0030854) | 3.36648950 |
| 53 | regulation of cell killing (GO:0031341) | 3.34347050 |
| 54 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.30743223 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.28795487 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.27372571 |
| 57 | positive regulation of cell killing (GO:0031343) | 3.26705134 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.25566755 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22185089 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19325547 |
| 61 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.15552093 |
| 62 | negative regulation of interleukin-1 production (GO:0032692) | 3.13753760 |
| 63 | mast cell activation involved in immune response (GO:0002279) | 3.10798124 |
| 64 | mast cell degranulation (GO:0043303) | 3.10798124 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.08832866 |
| 66 | regulation of memory T cell differentiation (GO:0043380) | 3.04616995 |
| 67 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.04353051 |
| 68 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.04079057 |
| 69 | alpha-beta T cell differentiation (GO:0046632) | 2.95082145 |
| 70 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.95004080 |
| 71 | regulation of T cell mediated immunity (GO:0002709) | 2.92979489 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 2.92467417 |
| 73 | positive regulation of T cell mediated immunity (GO:0002711) | 2.89256231 |
| 74 | T cell homeostasis (GO:0043029) | 2.88734365 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 2.87198856 |
| 76 | response to type I interferon (GO:0034340) | 2.85292246 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.85001290 |
| 78 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.84660892 |
| 79 | response to interferon-beta (GO:0035456) | 2.82410775 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.81772055 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.81772055 |
| 82 | regulation of alpha-beta T cell activation (GO:0046634) | 2.81138075 |
| 83 | leukocyte degranulation (GO:0043299) | 2.77606678 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.76630269 |
| 85 | negative regulation of innate immune response (GO:0045824) | 2.76478807 |
| 86 | dendritic cell chemotaxis (GO:0002407) | 2.76223491 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 2.74962060 |
| 88 | T cell differentiation (GO:0030217) | 2.72980551 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.68925604 |
| 90 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.68331294 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.67926859 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 2.67110391 |
| 93 | dendritic cell migration (GO:0036336) | 2.65910732 |
| 94 | alpha-beta T cell activation (GO:0046631) | 2.65178917 |
| 95 | Peyers patch development (GO:0048541) | 2.64587160 |
| 96 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.64587160 |
| 97 | neutrophil activation (GO:0042119) | 2.64563141 |
| 98 | T cell costimulation (GO:0031295) | 2.63307798 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.63275106 |
| 100 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.62449378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.63934669 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.38537144 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.10863615 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.52342127 |
| 5 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.36352348 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86904403 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76857021 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.76339111 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66635399 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.63485851 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26763026 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26327698 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21595833 |
| 14 | * GATA3_26560356_Chip-Seq_TH2_Human | 2.13524524 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12235562 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.10817193 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.08672814 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07862860 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05568530 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03198381 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02260643 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00730982 |
| 23 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.96276245 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.90228939 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87616831 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85067141 |
| 27 | * MAF_26560356_Chip-Seq_TH2_Human | 1.76724797 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71113585 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59857860 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56240212 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52372155 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46665774 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45733105 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44530082 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41635939 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41196035 |
| 37 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.39117795 |
| 38 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.36030619 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35148264 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32240095 |
| 41 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31450717 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29533587 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28470122 |
| 44 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28039085 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27684473 |
| 46 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27560253 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25502194 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22746874 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22186362 |
| 50 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.21727540 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19664864 |
| 52 | ERA_21632823_ChIP-Seq_H3396_Human | 1.18922488 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17892646 |
| 54 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17299024 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16735262 |
| 56 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12283844 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11253197 |
| 58 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09901993 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.08053047 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07797437 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07790077 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04479263 |
| 63 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.04175101 |
| 64 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04071094 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03031925 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02932447 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02660006 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02418064 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01997202 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00175147 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99637569 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99223153 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96255428 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95656140 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 0.94323550 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94303330 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93877929 |
| 78 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93791978 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93735482 |
| 80 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93170186 |
| 81 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93170186 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92531236 |
| 83 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92187283 |
| 84 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92045557 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90029116 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89839651 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89019650 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88697124 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86970918 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85299259 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84308693 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84205124 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83894219 |
| 94 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.82840521 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82795175 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82669156 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82335825 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81634119 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81258307 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80347462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.32901640 |
| 2 | MP0003724_increased_susceptibility_to | 3.55891088 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.54707033 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42055900 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.19785511 |
| 6 | MP0001800_abnormal_humoral_immune | 3.17656858 |
| 7 | MP0000685_abnormal_immune_system | 3.13509764 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.86877314 |
| 9 | MP0001790_abnormal_immune_system | 2.84924559 |
| 10 | MP0005387_immune_system_phenotype | 2.84924559 |
| 11 | MP0009785_altered_susceptibility_to | 2.64098449 |
| 12 | MP0002723_abnormal_immune_serum | 2.62378604 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.54180202 |
| 14 | MP0001819_abnormal_immune_cell | 2.50204676 |
| 15 | MP0005025_abnormal_response_to | 2.42590775 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.35742495 |
| 17 | MP0001873_stomach_inflammation | 2.27182568 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.24595810 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.17132270 |
| 20 | MP0002419_abnormal_innate_immunity | 2.06423251 |
| 21 | MP0002405_respiratory_system_inflammati | 2.05661755 |
| 22 | MP0002398_abnormal_bone_marrow | 1.97162844 |
| 23 | MP0000716_abnormal_immune_system | 1.95543164 |
| 24 | MP0003866_abnormal_defecation | 1.95053771 |
| 25 | MP0006082_CNS_inflammation | 1.92735582 |
| 26 | MP0000703_abnormal_thymus_morphology | 1.84676655 |
| 27 | MP0002933_joint_inflammation | 1.81914165 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.79709524 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.76539782 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.73639369 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.73209047 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.71564480 |
| 33 | MP0003646_muscle_fatigue | 1.69696590 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.66976843 |
| 35 | MP0002722_abnormal_immune_system | 1.58711960 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.57203169 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.52613232 |
| 38 | MP0002429_abnormal_blood_cell | 1.46236018 |
| 39 | MP0009764_decreased_sensitivity_to | 1.41539161 |
| 40 | MP0004381_abnormal_hair_follicle | 1.40584305 |
| 41 | MP0002102_abnormal_ear_morphology | 1.38449386 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.30165837 |
| 43 | MP0004147_increased_porphyrin_level | 1.24594348 |
| 44 | MP0004947_skin_inflammation | 1.24188415 |
| 45 | MP0005377_hearing/vestibular/ear_phenot | 1.23959565 |
| 46 | MP0003878_abnormal_ear_physiology | 1.23959565 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.23880094 |
| 48 | MP0002132_abnormal_respiratory_system | 1.21726723 |
| 49 | MP0008872_abnormal_physiological_respon | 1.20476112 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.18698144 |
| 51 | MP0005310_abnormal_salivary_gland | 1.17752218 |
| 52 | MP0004130_abnormal_muscle_cell | 1.16761917 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.15205003 |
| 54 | MP0008469_abnormal_protein_level | 1.14600938 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.13281486 |
| 56 | MP0004142_abnormal_muscle_tone | 1.13135120 |
| 57 | MP0000372_irregular_coat_pigmentation | 0.99084670 |
| 58 | MP0001663_abnormal_digestive_system | 0.97753694 |
| 59 | MP0001968_abnormal_touch/_nociception | 0.97289916 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.96836919 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 0.96290357 |
| 62 | MP0001851_eye_inflammation | 0.94206208 |
| 63 | MP0005464_abnormal_platelet_physiology | 0.93764947 |
| 64 | MP0003011_delayed_dark_adaptation | 0.92841767 |
| 65 | MP0003300_gastrointestinal_ulcer | 0.92722510 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.92359542 |
| 67 | MP0001919_abnormal_reproductive_system | 0.92190810 |
| 68 | MP0003787_abnormal_imprinting | 0.86901106 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.86036488 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.83017483 |
| 71 | MP0002163_abnormal_gland_morphology | 0.82224704 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.81926177 |
| 73 | MP0003303_peritoneal_inflammation | 0.81650872 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.81381739 |
| 75 | MP0003195_calcinosis | 0.79430784 |
| 76 | MP0002928_abnormal_bile_duct | 0.78554022 |
| 77 | MP0002006_tumorigenesis | 0.78101619 |
| 78 | MP0004043_abnormal_pH_regulation | 0.76405375 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.75545698 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.74138395 |
| 81 | MP0004742_abnormal_vestibular_system | 0.73778176 |
| 82 | MP0009745_abnormal_behavioral_response | 0.73242707 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.72789181 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.72270672 |
| 85 | MP0004885_abnormal_endolymph | 0.67735969 |
| 86 | MP0005390_skeleton_phenotype | 0.67158414 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.66418836 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.65432273 |
| 89 | MP0002009_preneoplasia | 0.65337782 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.64776198 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.64359823 |
| 92 | MP0003045_fibrosis | 0.64008579 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63418137 |
| 94 | MP0009763_increased_sensitivity_to | 0.60849378 |
| 95 | MP0005389_reproductive_system_phenotype | 0.60677313 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.60624275 |
| 97 | MP0004883_abnormal_blood_vessel | 0.59437153 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.59060300 |
| 99 | MP0005253_abnormal_eye_physiology | 0.57299941 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.56766829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.53679134 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.20042782 |
| 3 | Myositis (HP:0100614) | 4.38013410 |
| 4 | T lymphocytopenia (HP:0005403) | 4.31312734 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.15368624 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.11964687 |
| 7 | IgG deficiency (HP:0004315) | 4.00868820 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.90320809 |
| 9 | Optic neuritis (HP:0100653) | 3.88634707 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.88634707 |
| 11 | Abnormality of T cells (HP:0002843) | 3.82801709 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.78486086 |
| 13 | Pustule (HP:0200039) | 3.74813635 |
| 14 | Orchitis (HP:0100796) | 3.65727558 |
| 15 | Congenital stationary night blindness (HP:0007642) | 3.56972327 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.55207392 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.53771366 |
| 18 | Encephalitis (HP:0002383) | 3.51406527 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.13650525 |
| 20 | Increased IgM level (HP:0003496) | 3.12134027 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10748808 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10748808 |
| 23 | Abnormality of eosinophils (HP:0001879) | 2.97048231 |
| 24 | Meningitis (HP:0001287) | 2.88301031 |
| 25 | Pancreatic cysts (HP:0001737) | 2.85851352 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.83418019 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.82649364 |
| 28 | Hypochromic microcytic anemia (HP:0004840) | 2.79710864 |
| 29 | Hypochromic anemia (HP:0001931) | 2.78856774 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.76380686 |
| 31 | Leukocytosis (HP:0001974) | 2.74661868 |
| 32 | Keratoconjunctivitis (HP:0001096) | 2.70048867 |
| 33 | Eosinophilia (HP:0001880) | 2.68969736 |
| 34 | Combined immunodeficiency (HP:0005387) | 2.66727161 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.66664225 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.63819411 |
| 37 | Vasculitis (HP:0002633) | 2.62628531 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.62051688 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.56123065 |
| 40 | Granulocytopenia (HP:0001913) | 2.52705301 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.49323733 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.49323733 |
| 43 | Thyroiditis (HP:0100646) | 2.48422578 |
| 44 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.46077101 |
| 45 | Stomach cancer (HP:0012126) | 2.45670117 |
| 46 | Lymphopenia (HP:0001888) | 2.44709616 |
| 47 | Recurrent skin infections (HP:0001581) | 2.42535425 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.40176592 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.37993731 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.35786522 |
| 51 | Hemoptysis (HP:0002105) | 2.35378044 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.32638734 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.31997014 |
| 54 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.28853106 |
| 55 | Recurrent viral infections (HP:0004429) | 2.23695802 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22561694 |
| 57 | Obstructive lung disease (HP:0006536) | 2.22561694 |
| 58 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21704690 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20182613 |
| 60 | Type II lissencephaly (HP:0007260) | 2.16989638 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.16185491 |
| 62 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14981380 |
| 63 | Pancreatic fibrosis (HP:0100732) | 2.13866574 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.11002730 |
| 65 | IgM deficiency (HP:0002850) | 2.10537206 |
| 66 | Increased IgE level (HP:0003212) | 2.07908649 |
| 67 | Nephronophthisis (HP:0000090) | 2.03836820 |
| 68 | Chronic diarrhea (HP:0002028) | 2.03180616 |
| 69 | Hyperventilation (HP:0002883) | 2.02194493 |
| 70 | Hypoproteinemia (HP:0003075) | 2.00030565 |
| 71 | Aplastic anemia (HP:0001915) | 1.98642490 |
| 72 | True hermaphroditism (HP:0010459) | 1.98005174 |
| 73 | Spontaneous hematomas (HP:0007420) | 1.96698525 |
| 74 | Inability to walk (HP:0002540) | 1.96403487 |
| 75 | Chronic otitis media (HP:0000389) | 1.95760503 |
| 76 | Inflammation of the large intestine (HP:0002037) | 1.94746388 |
| 77 | Chronic sinusitis (HP:0011109) | 1.94247340 |
| 78 | B lymphocytopenia (HP:0010976) | 1.92844866 |
| 79 | Chest pain (HP:0100749) | 1.92692617 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.92571893 |
| 81 | Microcytic anemia (HP:0001935) | 1.91799315 |
| 82 | Anorexia (HP:0002039) | 1.91562956 |
| 83 | Verrucae (HP:0200043) | 1.90115830 |
| 84 | Papilloma (HP:0012740) | 1.90115830 |
| 85 | Prolonged bleeding time (HP:0003010) | 1.89786572 |
| 86 | Hemiplegia (HP:0002301) | 1.88148470 |
| 87 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87724943 |
| 88 | Clumsiness (HP:0002312) | 1.87344240 |
| 89 | Abnormal drinking behavior (HP:0030082) | 1.87341942 |
| 90 | Polydipsia (HP:0001959) | 1.87341942 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 1.86889726 |
| 92 | Papilledema (HP:0001085) | 1.86824774 |
| 93 | Joint swelling (HP:0001386) | 1.85564793 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.84517208 |
| 95 | Keratitis (HP:0000491) | 1.83612012 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82523365 |
| 97 | Pulmonary embolism (HP:0002204) | 1.81730139 |
| 98 | Microretrognathia (HP:0000308) | 1.80887419 |
| 99 | Abnormality of the renal medulla (HP:0100957) | 1.79323384 |
| 100 | Episodic fever (HP:0001954) | 1.78911944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.61193456 |
| 2 | TXK | 4.53168817 |
| 3 | TAOK3 | 4.39308227 |
| 4 | GRK6 | 2.52739366 |
| 5 | FES | 2.37751275 |
| 6 | ITK | 2.28166854 |
| 7 | TNK2 | 2.19871680 |
| 8 | ADRBK2 | 2.19157879 |
| 9 | RIPK4 | 2.16265091 |
| 10 | CAMKK2 | 2.15899354 |
| 11 | ACVR1B | 2.11308211 |
| 12 | ZAP70 | 1.95885695 |
| 13 | FRK | 1.93339188 |
| 14 | IKBKE | 1.91134877 |
| 15 | SYK | 1.84590519 |
| 16 | BTK | 1.83276425 |
| 17 | SIK2 | 1.79782480 |
| 18 | TLK1 | 1.76986814 |
| 19 | TYK2 | 1.71531780 |
| 20 | JAK3 | 1.68718118 |
| 21 | CAMKK1 | 1.67972519 |
| 22 | LCK | 1.65803802 |
| 23 | CSK | 1.64593535 |
| 24 | IRAK4 | 1.63951469 |
| 25 | BMPR1B | 1.57059670 |
| 26 | KDR | 1.54207037 |
| 27 | IKBKB | 1.47123619 |
| 28 | GRK1 | 1.42715260 |
| 29 | TEC | 1.40544644 |
| 30 | DAPK2 | 1.34056078 |
| 31 | HCK | 1.32660946 |
| 32 | LYN | 1.32338322 |
| 33 | PRKCQ | 1.29524294 |
| 34 | ZAK | 1.25392737 |
| 35 | KIT | 1.24142685 |
| 36 | TESK2 | 1.18939311 |
| 37 | PASK | 1.18193345 |
| 38 | NLK | 1.17915619 |
| 39 | MARK3 | 1.16894001 |
| 40 | SIK3 | 1.11071268 |
| 41 | BLK | 1.10305735 |
| 42 | TBK1 | 1.08458340 |
| 43 | MAP4K2 | 1.06904102 |
| 44 | WNK4 | 1.05187952 |
| 45 | MAPK13 | 1.03175507 |
| 46 | MAP3K11 | 0.96495179 |
| 47 | PTK2B | 0.95443051 |
| 48 | JAK1 | 0.92349164 |
| 49 | MAP2K6 | 0.90828117 |
| 50 | MAP2K2 | 0.90489870 |
| 51 | NUAK1 | 0.88896554 |
| 52 | ADRBK1 | 0.87111685 |
| 53 | MAP3K14 | 0.84252852 |
| 54 | PINK1 | 0.80457758 |
| 55 | TGFBR1 | 0.75580776 |
| 56 | EPHB1 | 0.75521386 |
| 57 | CSF1R | 0.74242130 |
| 58 | MAP3K7 | 0.73701532 |
| 59 | NTRK2 | 0.72907416 |
| 60 | HIPK2 | 0.72777991 |
| 61 | MAP2K3 | 0.69068959 |
| 62 | PIM1 | 0.68828014 |
| 63 | MAPK15 | 0.68754222 |
| 64 | PRKCH | 0.65854592 |
| 65 | INSRR | 0.65631541 |
| 66 | GRK7 | 0.65242824 |
| 67 | JAK2 | 0.61664129 |
| 68 | WNK3 | 0.61045790 |
| 69 | PRKD2 | 0.60435262 |
| 70 | BCKDK | 0.60188261 |
| 71 | FGR | 0.59420669 |
| 72 | STK11 | 0.57163690 |
| 73 | MAPK12 | 0.57036226 |
| 74 | RPS6KA6 | 0.56489189 |
| 75 | MAP3K13 | 0.52112096 |
| 76 | ERN1 | 0.52004176 |
| 77 | PDK1 | 0.49286122 |
| 78 | CDK19 | 0.47857422 |
| 79 | CAMK4 | 0.44067576 |
| 80 | TYRO3 | 0.43798724 |
| 81 | OXSR1 | 0.43702168 |
| 82 | IRAK1 | 0.42463977 |
| 83 | CHUK | 0.42205224 |
| 84 | MAPK7 | 0.41692628 |
| 85 | MAPK11 | 0.40398161 |
| 86 | STK38 | 0.39303588 |
| 87 | TAOK1 | 0.39102602 |
| 88 | RPS6KA5 | 0.39050703 |
| 89 | FYN | 0.38826424 |
| 90 | MELK | 0.36414264 |
| 91 | CASK | 0.35883762 |
| 92 | CAMK1 | 0.34945696 |
| 93 | STK10 | 0.31849816 |
| 94 | PAK3 | 0.28633250 |
| 95 | CDK4 | 0.27233410 |
| 96 | EPHA3 | 0.26138109 |
| 97 | MAPKAPK3 | 0.25905472 |
| 98 | CDC42BPA | 0.25857610 |
| 99 | PRKCZ | 0.24666430 |
| 100 | ABL1 | 0.24363873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.27875970 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.28815913 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.26155626 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.21373259 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.82179228 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.79962451 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.60371368 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.49039377 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45675936 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20304209 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02413015 |
| 12 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.00355783 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96510755 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.80580944 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.77038265 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76320799 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57563605 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57503083 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53194779 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51256152 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50480884 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48757386 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45001375 |
| 24 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44607428 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41994185 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36650908 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35295769 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31917021 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26258535 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24132624 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22153650 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.22106638 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.21618385 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17225468 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16376209 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12998766 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10307620 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09984964 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04236447 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00820670 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.00134051 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95801191 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93386913 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92291192 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89895528 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89891017 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85267486 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81504099 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80204746 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80088307 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.76134869 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.73333411 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73061032 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.71007759 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68346092 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66847038 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66339829 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64314417 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.64262445 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63523734 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.59236216 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57497946 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56031225 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54129680 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53451793 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53193878 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52930423 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51855270 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50911177 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.50779554 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49500487 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47658704 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44447196 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.43938763 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.43241563 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41864330 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.38917606 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38754937 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.37347147 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36972933 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36712416 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36457045 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.33386442 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32233132 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.32226841 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31488901 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31146177 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.29493055 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29115125 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.28849663 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28056033 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27242634 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.26805756 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26681575 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.26637884 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26265163 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25056646 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.23361355 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23133593 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23117045 |

